Eocene Ltd. (EOCN)
3.54
-0.08
(-2.21%)
USD |
NASDAQ |
Oct 09, 16:00
3.51
-0.03
(-0.85%)
After-Hours: 20:00
Eocene Enterprise Value : -7.716M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | -7.716M |
| October 08, 2026 | -7.636M |
| October 07, 2026 | -7.798M |
| October 06, 2026 | -7.896M |
| October 05, 2026 | -7.806M |
| October 02, 2026 | -7.646M |
| October 01, 2026 | -7.851M |
| September 30, 2026 | -7.766M |
| September 29, 2026 | -7.706M |
| September 28, 2026 | -7.626M |
| September 25, 2026 | -7.626M |
| September 24, 2026 | -7.636M |
| September 23, 2026 | -7.636M |
| September 22, 2026 | -7.631M |
| September 21, 2026 | -7.756M |
| September 18, 2026 | -7.886M |
| September 17, 2026 | -7.776M |
| September 16, 2026 | -7.846M |
| September 15, 2026 | -7.631M |
| September 14, 2026 | -7.436M |
| September 11, 2026 | -7.416M |
| September 10, 2026 | -7.225M |
| September 09, 2026 | -6.624M |
| September 08, 2026 | -7.431M |
| September 04, 2026 | -7.376M |
| Date | Value |
|---|---|
| September 03, 2026 | -7.336M |
| September 02, 2026 | -7.136M |
| September 01, 2026 | -7.330M |
| August 31, 2026 | -7.135M |
| August 28, 2026 | -7.090M |
| August 27, 2026 | -6.949M |
| August 26, 2026 | -6.925M |
| August 25, 2026 | -6.950M |
| August 24, 2026 | -7.205M |
| August 21, 2026 | -6.95M |
| August 20, 2026 | -6.695M |
| August 19, 2026 | -6.484M |
| August 18, 2026 | -6.773M |
| August 17, 2026 | -7.148M |
| August 14, 2026 | -7.070M |
| August 13, 2026 | -7.007M |
| August 12, 2026 | -6.775M |
| August 11, 2026 | -6.800M |
| August 10, 2026 | -6.510M |
| August 07, 2026 | -6.439M |
| August 06, 2026 | -6.462M |
| August 05, 2026 | -6.614M |
| August 04, 2026 | -6.651M |
| August 03, 2026 | -6.574M |
| July 31, 2026 | -6.286M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| BioLineRx Ltd. | 7.392M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 407.84M |
| Can-Fite BioPharma Ltd. | -4.811M |
| Revium Recovery, Inc. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.723M |
| Total Expenses (Quarterly) | 2.723M |
| EPS Diluted (Quarterly) | -2.860 |
| Earnings Yield | -390.0% |
| Normalized Earnings Yield | -343.50 |